Pre-order Enquiry
Request Free Sample
Global Colorectal Cancer Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18595421 | Publishing Date : 18-Jun-2021 | No. of pages : 128
Detailed TOC of Global Colorectal Cancer Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Colorectal Cancer Drugs Market Overview1.1 Colorectal Cancer Drugs Product Overview
1.2 Colorectal Cancer Drugs Market Segment
1.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.2.3 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.2.4 BRAF or MEK Inhibitors
1.2.5 Tyrosine Kinase (TKI) Inhibitors
1.2.6 Immunomodulators
1.3 Global Colorectal Cancer Drugs Market Size
1.3.1 Global Colorectal Cancer Drugs Market Size Overview (2016-2027)
1.3.2 Global Colorectal Cancer Drugs Historic Market Size Review (2016-2021)
1.3.2.1 Global Colorectal Cancer Drugs Sales Breakdown in Volume (2016-2021)
1.3.2.2 Global Colorectal Cancer Drugs Sales Breakdown in Value (2016-2021)
1.3.2.3 Global Colorectal Cancer Drugs Average Selling Price (ASP) (2016-2021)
1.3.3 Global Colorectal Cancer Drugs Forecasted Market Size (2022-2027)
1.3.3.1 Global Colorectal Cancer Drugs Sales Breakdown in Volume (2022-2027)
1.3.3.2 Global Colorectal Cancer Drugs Sales Breakdown in Value (2022-2027)
1.3.3.3 Global Colorectal Cancer Drugs Average Selling Price (ASP) (2022-2027)
1.4 Key Regions Market Size Segment
1.4.1 North America Colorectal Cancer Drugs Sales Breakdown (2016-2021)
1.4.2 Europe Colorectal Cancer Drugs Sales Breakdown (2016-2021)
1.4.3 Asia-Pacific Colorectal Cancer Drugs Sales Breakdown (2016-2021)
1.4.4 Latin America Colorectal Cancer Drugs Sales Breakdown (2016-2021)
1.4.5 Middle East and Africa Colorectal Cancer Drugs Sales Breakdown (2016-2021)
2 Global Colorectal Cancer Drugs Market Competition by Company
2.1 Global Top Players by Colorectal Cancer Drugs Sales (2016-2021)
2.2 Global Top Players by Colorectal Cancer Drugs Revenue (2016-2021)
2.3 Global Top Players Colorectal Cancer Drugs Price (2016-2021)
2.4 Global Top Manufacturers Colorectal Cancer Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Colorectal Cancer Drugs Market Competitive Situation and Trends
2.5.1 Colorectal Cancer Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Colorectal Cancer Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Colorectal Cancer Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Colorectal Cancer Drugs Market
2.8 Key Manufacturers Colorectal Cancer Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Colorectal Cancer Drugs Status and Outlook by Region
3.1 Global Colorectal Cancer Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Colorectal Cancer Drugs Historic Market Size by Region
3.2.1 Global Colorectal Cancer Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Colorectal Cancer Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Colorectal Cancer Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Colorectal Cancer Drugs Forecasted Market Size by Region
3.3.1 Global Colorectal Cancer Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Colorectal Cancer Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Colorectal Cancer Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Colorectal Cancer Drugs
4.1 Colorectal Cancer Drugs Market Segment
4.1.1 Radiotherapy
4.1.2 Chemotherapy
4.2 Global Colorectal Cancer Drugs Market Size
4.2.1 Global Colorectal Cancer Drugs Market Size Overview (2016-2027)
4.2.2 Global Colorectal Cancer Drugs Historic Market Size Review (2016-2021)
4.2.2.1 Global Colorectal Cancer Drugs Sales Breakdown in Volume, (2016-2021)
4.2.2.2 Global Colorectal Cancer Drugs Sales Breakdown in Value, (2016-2021)
4.2.2.3 Global Colorectal Cancer Drugs Average Selling Price (ASP) (2016-2021)
4.2.3 Global Colorectal Cancer Drugs Forecasted Market Size (2022-2027)
4.2.3.1 Global Colorectal Cancer Drugs Sales Breakdown in Volume, (2022-2027)
4.2.3.2 Global Colorectal Cancer Drugs Sales Breakdown in Value, (2022-2027)
4.2.3.3 Global Colorectal Cancer Drugs Average Selling Price (ASP) (2022-2027)
4.3 Key Regions Market Size Segment
4.3.1 North America Colorectal Cancer Drugs Sales Breakdown (2016-2021)
4.3.2 Europe Colorectal Cancer Drugs Sales Breakdown (2016-2021)
4.3.3 Asia-Pacific Colorectal Cancer Drugs Sales Breakdown (2016-2021)
4.3.4 Latin America Colorectal Cancer Drugs Sales Breakdown (2016-2021)
4.3.5 Middle East and Africa Colorectal Cancer Drugs Sales Breakdown (2016-2021)
5 North America Colorectal Cancer Drugs by Country
5.1 North America Colorectal Cancer Drugs Historic Market Size by Country
5.1.1 North America Colorectal Cancer Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Colorectal Cancer Drugs Sales in Value by Country (2016-2021)
5.2 North America Colorectal Cancer Drugs Forecasted Market Size by Country
5.2.1 North America Colorectal Cancer Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Colorectal Cancer Drugs Sales in Value by Country (2022-2027)
6 Europe Colorectal Cancer Drugs by Country
6.1 Europe Colorectal Cancer Drugs Historic Market Size by Country
6.1.1 Europe Colorectal Cancer Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Colorectal Cancer Drugs Sales in Value by Country (2016-2021)
6.2 Europe Colorectal Cancer Drugs Forecasted Market Size by Country
6.2.1 Europe Colorectal Cancer Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Colorectal Cancer Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Colorectal Cancer Drugs by Region
7.1 Asia-Pacific Colorectal Cancer Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Colorectal Cancer Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Colorectal Cancer Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Colorectal Cancer Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Colorectal Cancer Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Colorectal Cancer Drugs Sales in Value by Region (2022-2027)
8 Latin America Colorectal Cancer Drugs by Country
8.1 Latin America Colorectal Cancer Drugs Historic Market Size by Country
8.1.1 Latin America Colorectal Cancer Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Colorectal Cancer Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Colorectal Cancer Drugs Forecasted Market Size by Country
8.2.1 Latin America Colorectal Cancer Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Colorectal Cancer Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Colorectal Cancer Drugs by Country
9.1 Middle East and Africa Colorectal Cancer Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Colorectal Cancer Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Colorectal Cancer Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Colorectal Cancer Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Colorectal Cancer Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Colorectal Cancer Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Colorectal Cancer Drugs Business
10.1 AB Science
10.1.1 AB Science Corporation Information
10.1.2 AB Science Introduction and Business Overview
10.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 AB Science Colorectal Cancer Drugs Products Offered
10.1.5 AB Science Recent Development
10.2 Amgen
10.2.1 Amgen Corporation Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 AB Science Colorectal Cancer Drugs Products Offered
10.2.5 Amgen Recent Development
10.3 Array BioPharma
10.3.1 Array BioPharma Corporation Information
10.3.2 Array BioPharma Introduction and Business Overview
10.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Array BioPharma Colorectal Cancer Drugs Products Offered
10.3.5 Array BioPharma Recent Development
10.4 Bayer
10.4.1 Bayer Corporation Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bayer Colorectal Cancer Drugs Products Offered
10.4.5 Bayer Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Corporation Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Corporation Information
10.6.2 Bristol-Myers Squibb Introduction and Business Overview
10.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Offered
10.6.5 Bristol-Myers Squibb Recent Development
10.7 Elli Lilly
10.7.1 Elli Lilly Corporation Information
10.7.2 Elli Lilly Introduction and Business Overview
10.7.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Elli Lilly Colorectal Cancer Drugs Products Offered
10.7.5 Elli Lilly Recent Development
10.8 Roch
10.8.1 Roch Corporation Information
10.8.2 Roch Introduction and Business Overview
10.8.3 Roch Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Roch Colorectal Cancer Drugs Products Offered
10.8.5 Roch Recent Development
10.9 Hutchison MediPharma
10.9.1 Hutchison MediPharma Corporation Information
10.9.2 Hutchison MediPharma Introduction and Business Overview
10.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Hutchison MediPharma Colorectal Cancer Drugs Products Offered
10.9.5 Hutchison MediPharma Recent Development
10.10 Merck & Co., Inc.
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Colorectal Cancer Drugs Product Category, Application and Specification
10.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Merck & Co., Inc. Recent Development
10.11 Mologen
10.11.1 Mologen Corporation Information
10.11.2 Mologen Introduction and Business Overview
10.11.3 Mologen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Mologen Colorectal Cancer Drugs Products Offered
10.11.5 Mologen Recent Development
10.12 Regeneron
10.12.1 Regeneron Corporation Information
10.12.2 Regeneron Introduction and Business Overview
10.12.3 Regeneron Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Regeneron Colorectal Cancer Drugs Products Offered
10.12.5 Regeneron Recent Development
10.13 Sanofi
10.13.1 Sanofi Corporation Information
10.13.2 Sanofi Introduction and Business Overview
10.13.3 Sanofi Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Sanofi Colorectal Cancer Drugs Products Offered
10.13.5 Sanofi Recent Development
10.14 Sumitomo Dainippon
10.14.1 Sumitomo Dainippon Corporation Information
10.14.2 Sumitomo Dainippon Introduction and Business Overview
10.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Products Offered
10.14.5 Sumitomo Dainippon Recent Development
10.15 Taiho Pharmaceutical
10.15.1 Taiho Pharmaceutical Corporation Information
10.15.2 Taiho Pharmaceutical Introduction and Business Overview
10.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Products Offered
10.15.5 Taiho Pharmaceutical Recent Development
10.16 Vaccinogen
10.16.1 Vaccinogen Corporation Information
10.16.2 Vaccinogen Introduction and Business Overview
10.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Vaccinogen Colorectal Cancer Drugs Products Offered
10.16.5 Vaccinogen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Colorectal Cancer Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Colorectal Cancer Drugs Industrial Chain Analysis
11.4 Colorectal Cancer Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Colorectal Cancer Drugs Distributors
12.3 Colorectal Cancer Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Colorectal Cancer Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 2. Major Company of Epidermal Growth Factor Receptor (EGFR) Inhibitors
Table 3. Major Company of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
Table 4. Major Company of BRAF or MEK Inhibitors
Table 5. Major Company of Tyrosine Kinase (TKI) Inhibitors
Table 6. Major Company of Immunomodulators
Table 7. Global Colorectal Cancer Drugs Sales 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 9. Global Colorectal Cancer Drugs Sales Market Share in Volume (2016-2021)
Table 10. Global Colorectal Cancer Drugs Sales (2016-2021) & (US& Million)
Table 11. Global Colorectal Cancer Drugs Market Share in Value (2016-2021)
Table 12. Global Colorectal Cancer Drugs Price (2016-2021) & (USD/Kg)
Table 13. Global Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 14. Global Colorectal Cancer Drugs Sales Market Share in Volume (2022-2027)
Table 15. Global Colorectal Cancer Drugs Sales (2022-2027) & (US$ Million)
Table 16. Global Colorectal Cancer Drugs Sales Market Share in Value (2022-2027)
Table 17. Global Colorectal Cancer Drugs Price (2022-2027) & (USD/Kg)
Table 18. North America Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 19. North America Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 20. Europe Colorectal Cancer Drugs Sales (MT) (2016-2021)
Table 21. Europe Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 22. Asia-Pacific Colorectal Cancer Drugs Sales (MT) (2016-2021)
Table 23. Asia-Pacific Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 24. Latin America Colorectal Cancer Drugs Sales (MT) (2016-2021)
Table 25. Latin America Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 26. Middle East and Africa Colorectal Cancer Drugs Sales (MT) (2016-2021)
Table 27. Middle East and Africa Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 28. Global Colorectal Cancer Drugs Sales by Company (2016-2021) & (MT)
Table 29. Global Colorectal Cancer Drugs Sales Share by Company (2016-2021)
Table 30. Global Colorectal Cancer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 31. Global Colorectal Cancer Drugs Revenue Share by Company (2016-2021)
Table 32. Global Market Colorectal Cancer Drugs Price by Company (2016-2021) & (USD/Kg)
Table 33. Global Colorectal Cancer Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Colorectal Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Colorectal Cancer Drugs as of 2020
Table 36. Date of Key Manufacturers Enter into Colorectal Cancer Drugs Market
Table 37. Key Manufacturers Colorectal Cancer Drugs Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Colorectal Cancer Drugs Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 40. Global Colorectal Cancer Drugs Sales by Region (2016-2021) & (MT)
Table 41. Global Colorectal Cancer Drugs Sales Market Share in Volume by Region (2016-2021)
Table 42. Global Colorectal Cancer Drugs Sales by Region (2016-2021) & (US$ Million)
Table 43. Global Colorectal Cancer Drugs Sales Market Share in Value by Region (2016-2021)
Table 44. Global Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 45. Global Colorectal Cancer Drugs Sales by Region (2022-2027) & (MT)
Table 46. Global Colorectal Cancer Drugs Sales Market Share in Volume by Region (2022-2027)
Table 47. Global Colorectal Cancer Drugs Sales by Region (2022-2027) & (US$ Million)
Table 48. Global Colorectal Cancer Drugs Sales Market Share in Value by Region (2022-2027)
Table 49. Global Colorectal Cancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2022-2027)
Table 50. Global Colorectal Cancer Drugs Sales : 2016 VS 2021 VS 2027 (US$ Million)
Table 51. Global Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 52. Global Colorectal Cancer Drugs Sales Market Share in Volume (2016-2021)
Table 53. Global Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 54. Global Colorectal Cancer Drugs Sales Market Share in Value (2016-2021)
Table 55. Global Colorectal Cancer Drugs Price (2016-2021) & (USD/Kg)
Table 56. Global Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 57. Global Colorectal Cancer Drugs Sales Market Share in Volume (2022-2027)
Table 58. Global Colorectal Cancer Drugs Sales (2022-2027) & (US$ Million)
Table 59. Global Colorectal Cancer Drugs Sales Market Share in Value (2022-2027)
Table 60. Global Colorectal Cancer Drugs Price (2022-2027) & (USD/Kg)
Table 61. North America Colorectal Cancer Drugs Sales (2016-2021) (MT)
Table 62. North America Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 63. North America Colorectal Cancer Drugs Sales Market Share in Value in 2020
Table 64. Europe Colorectal Cancer Drugs Sales (2016-2021) (MT)
Table 65. Europe Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 66. Europe Colorectal Cancer Drugs Sales Market Share in Value in 2020
Table 67. Asia-Pacific Colorectal Cancer Drugs Sales (2016-2021) (MT)
Table 68. Asia-Pacific Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 69. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Value in 2020
Table 70. Latin America Colorectal Cancer Drugs Sales (2016-2021) (MT)
Table 71. Latin America Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 72. Latin America Colorectal Cancer Drugs Sales Market Share in Value in 2020
Table 73. Middle East and Africa Colorectal Cancer Drugs Sales (2016-2021) (MT)
Table 74. Middle East and Africa Colorectal Cancer Drugs Sales (2016-2021) & (US$ Million)
Table 75. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value in 2020
Table 76. North America Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT)
Table 77. North America Colorectal Cancer Drugs Sales Market Share in Volume by Country (2016-2021)
Table 78. North America Colorectal Cancer Drugs Sales by Country (2016-2021) & (US$ Million)
Table 79. North America Colorectal Cancer Drugs Sales Market Share in Value by Country (2016-2021)
Table 80. North America Colorectal Cancer Drugs Sales by Country (2022-2027) & (MT)
Table 81. North America Colorectal Cancer Drugs Sales Market Share in Volume by Country (2022-2027)
Table 82. North America Colorectal Cancer Drugs Sales by Country (2022-2027) & (US$ Million)
Table 83. North America Colorectal Cancer Drugs Sales Market Share in Value by Country (2022-2027)
Table 84. Europe Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT)
Table 85. Europe Colorectal Cancer Drugs Sales Market Share in Volume by Country (2016-2021)
Table 86. Europe Colorectal Cancer Drugs Sales by Country (2016-2021) & (US$ Million)
Table 87. Europe Colorectal Cancer Drugs Sales Market Share in Value by Country (2016-2021)
Table 88. Europe Colorectal Cancer Drugs Sales by Country (2022-2027) & (MT)
Table 89. Europe Colorectal Cancer Drugs Sales Market Share in Volume by Country (2022-2027)
Table 90. Europe Colorectal Cancer Drugs Sales by Country (2022-2027) & (US$ Million)
Table 91. Europe Colorectal Cancer Drugs Sales Market Share in Value by Country (2022-2027)
Table 92. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2016-2021) & (MT)
Table 93. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Volume by Region (2016-2021)
Table 94. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2016-2021) & (US$ Million)
Table 95. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Value by Region (2016-2021)
Table 96. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2022-2027) & (MT)
Table 97. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Volume by Region (2022-2027)
Table 98. Asia-Pacific Colorectal Cancer Drugs Sales by Region (2022-2027) & (US$ Million)
Table 99. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Value by Region (2022-2027)
Table 100. Latin America Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT)
Table 101. Latin America Colorectal Cancer Drugs Sales Market Share in Volume by Country (2016-2021)
Table 102. Latin America Colorectal Cancer Drugs Sales by Country (2016-2021) & (US$ Million)
Table 103. Latin America Colorectal Cancer Drugs Sales Market Share in Value by Country (2016-2021)
Table 104. Latin America Colorectal Cancer Drugs Sales by Country (2022-2027) & (MT)
Table 105. Latin America Colorectal Cancer Drugs Sales Market Share in Volume by Country (2022-2027)
Table 106. Latin America Colorectal Cancer Drugs Sales by Country (2022-2027) & (US$ Million)
Table 107. Latin America Colorectal Cancer Drugs Sales Market Share in Value by Country (2022-2027)
Table 108. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2016-2021) & (MT)
Table 109. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Volume by Country (2016-2021)
Table 110. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2016-2021) & (US$ Million)
Table 111. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value by Country (2016-2021)
Table 112. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2022-2027) & (MT)
Table 113. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Volume by Country (2022-2027)
Table 114. Middle East and Africa Colorectal Cancer Drugs Sales by Country (2022-2027) & (US$ Million)
Table 115. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value by Country (2022-2027)
Table 116. AB Science Corporation Information
Table 117. AB Science Introduction and Business Overview
Table 118. AB Science Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 119. AB Science Colorectal Cancer Drugs Product
Table 120. AB Science Recent Development
Table 121. Amgen Corporation Information
Table 122. Amgen Introduction and Business Overview
Table 123. Amgen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 124. Amgen Colorectal Cancer Drugs Product
Table 125. Amgen Recent Development
Table 126. Array BioPharma Corporation Information
Table 127. Array BioPharma Introduction and Business Overview
Table 128. Array BioPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 129. Array BioPharma Colorectal Cancer Drugs Product
Table 130. Array BioPharma Recent Development
Table 131. Bayer Corporation Information
Table 132. Bayer Introduction and Business Overview
Table 133. Bayer Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 134. Bayer Colorectal Cancer Drugs Product
Table 135. Bayer Recent Development
Table 136. Boehringer Ingelheim Corporation Information
Table 137. Boehringer Ingelheim Introduction and Business Overview
Table 138. Boehringer Ingelheim Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 139. Boehringer Ingelheim Colorectal Cancer Drugs Product
Table 140. Boehringer Ingelheim Recent Development
Table 141. Bristol-Myers Squibb Corporation Information
Table 142. Bristol-Myers Squibb Introduction and Business Overview
Table 143. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 144. Bristol-Myers Squibb Colorectal Cancer Drugs Product
Table 145. Bristol-Myers Squibb Recent Development
Table 146. Elli Lilly Corporation Information
Table 147. Elli Lilly Introduction and Business Overview
Table 148. Elli Lilly Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 149. Elli Lilly Colorectal Cancer Drugs Product
Table 150. Elli Lilly Recent Development
Table 151. Roch Corporation Information
Table 152. Roch Introduction and Business Overview
Table 153. Roch Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 154. Roch Colorectal Cancer Drugs Product
Table 155. Roch Recent Development
Table 156. Hutchison MediPharma Corporation Information
Table 157. Hutchison MediPharma Introduction and Business Overview
Table 158. Hutchison MediPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 159. Hutchison MediPharma Colorectal Cancer Drugs Product
Table 160. Hutchison MediPharma Recent Development
Table 161. Merck & Co., Inc. Corporation Information
Table 162. Merck & Co., Inc. Introduction and Business Overview
Table 163. Merck & Co., Inc. Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 164. Merck & Co., Inc. Colorectal Cancer Drugs Product
Table 165. Merck & Co., Inc. Recent Development
Table 166. Mologen Corporation Information
Table 167. Mologen Introduction and Business Overview
Table 168. Mologen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 169. Mologen Colorectal Cancer Drugs Product
Table 170. Mologen Recent Development
Table 171. Regeneron Corporation Information
Table 172. Regeneron Introduction and Business Overview
Table 173. Regeneron Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 174. Regeneron Colorectal Cancer Drugs Product
Table 175. Regeneron Recent Development
Table 176. Sanofi Corporation Information
Table 177. Sanofi Introduction and Business Overview
Table 178. Sanofi Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 179. Sanofi Colorectal Cancer Drugs Product
Table 180. Sanofi Recent Development
Table 181. Sumitomo Dainippon Corporation Information
Table 182. Sumitomo Dainippon Introduction and Business Overview
Table 183. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 184. Sumitomo Dainippon Colorectal Cancer Drugs Product
Table 185. Sumitomo Dainippon Recent Development
Table 186. Taiho Pharmaceutical Corporation Information
Table 187. Taiho Pharmaceutical Introduction and Business Overview
Table 188. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 189. Taiho Pharmaceutical Colorectal Cancer Drugs Product
Table 190. Taiho Pharmaceutical Recent Development
Table 191. Vaccinogen Corporation Information
Table 192. Vaccinogen Introduction and Business Overview
Table 193. Vaccinogen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 194. Vaccinogen Colorectal Cancer Drugs Product
Table 195. Vaccinogen Recent Development
Table 196. Key Raw Materials Lists
Table 197. Raw Materials Key Suppliers Lists
Table 198. Colorectal Cancer Drugs Market Trends
Table 199. Colorectal Cancer Drugs Market Drivers
Table 200. Colorectal Cancer Drugs Market Challenges
Table 201. Colorectal Cancer Drugs Market Restraints
Table 202. Colorectal Cancer Drugs Distributors List
Table 203. Colorectal Cancer Drugs Downstream Customers
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
List of Figures
Figure 1. Colorectal Cancer Drugs Product Picture
Figure 2. Global Colorectal Cancer Drugs Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Colorectal Cancer Drugs Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Colorectal Cancer Drugs Sales Status and Outlook (2016-2027) & (MT)
Figure 5. Product Picture of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Figure 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales YoY Growth (2016-2021) & (MT)
Figure 7. Product Picture of Epidermal Growth Factor Receptor (EGFR) Inhibitors
Figure 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Sales YoY Growth (2016-2021) & (MT)
Figure 9. Product Picture of Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
Figure 10. Global Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Sales YoY Growth (2016-2021) & (MT)
Figure 11. Product Picture of BRAF or MEK Inhibitors
Figure 12. Global BRAF or MEK Inhibitors Sales YoY Growth (2016-2021) & (MT)
Figure 13. Product Picture of Tyrosine Kinase (TKI) Inhibitors
Figure 14. Global Tyrosine Kinase (TKI) Inhibitors Sales YoY Growth (2016-2021) & (MT)
Figure 15. Product Picture of Immunomodulators
Figure 16. Global Immunomodulators Sales YoY Growth (2016-2021) & (MT)
Figure 17. Global Colorectal Cancer Drugs Sales (2016-2027) & (US$ Million)
Figure 18. Global Colorectal Cancer Drugs Sales Market Share in Volume (2016-2021)
Figure 19. Global Colorectal Cancer Drugs Sales Market Share in Value (2016-2021)
Figure 20. Global Colorectal Cancer Drugs Sales Market Share in Volume (2022-2027)
Figure 21. Global Colorectal Cancer Drugs Sales Market Share in Value (2022-2027)
Figure 22. North America Colorectal Cancer Drugs Sales Market Share in Volume in 2020
Figure 23. North America Colorectal Cancer Drugs Sales Market Share in Value in 2020
Figure 24. Europe Colorectal Cancer Drugs Sales Market Share in Volume in 2020
Figure 25. Europe Colorectal Cancer Drugs Sales Market Share in Value in 2020
Figure 26. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Volume in 2020
Figure 27. Asia-Pacific Colorectal Cancer Drugs Sales Market Share in Value in 2020
Figure 28. Latin America Colorectal Cancer Drugs Sales Market Share in Volume in 2020
Figure 29. Latin America Colorectal Cancer Drugs Sales Market Share in Value in 2020
Figure 30. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Volume in 2020
Figure 31. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value in 2020
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Colorectal Cancer Drugs Sales in 2020
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Colorectal Cancer Drugs Revenue in 2020
Figure 34. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 35. Product Picture of Radiotherapy
Figure 36. Global Radiotherapy Sales YoY Growth (2016-2027) & (MT)
Figure 37. Product Picture of Chemotherapy
Figure 38. Global Chemotherapy Sales YoY Growth (2016-2027) & (MT)
Figure 39. Global Colorectal Cancer Drugs Sales (2016-2027) & (US$ Million)
Figure 40. Global Colorectal Cancer Drugs Sales Market Share in Volume (2016-2021)
Figure 41. Global Colorectal Cancer Drugs Sales Market Share in Value (2016-2021)
Figure 42. Global Colorectal Cancer Drugs Sales Market Share in Volume (2022-2027)
Figure 43. North America Colorectal Cancer Drugs Sales Market Share in Volume in 2020
Figure 44. Latin America Colorectal Cancer Drugs Sales Market Share in Value in 2020
Figure 45. Middle East and Africa Colorectal Cancer Drugs Sales Market Share in Value in 2020
Figure 46. Key Raw Materials Price
Figure 47. Colorectal Cancer Drugs Manufacturing Cost Structure
Figure 48. Colorectal Cancer Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Keyplayers in Global Colorectal Cancer Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
AB ScienceAmgen
Array BioPharma
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Elli Lilly
Roch
Hutchison MediPharma
Merck & Co., Inc.
Mologen
Regeneron
Sanofi
Sumitomo Dainippon
Taiho Pharmaceutical
Vaccinogen
Request Sample
Request Discount
